PHR Phreesia, Inc.
NYSE · SEC CIK 1412408 · EDGAR
- Bought, last 12 months
- $28.77M 2 purchases by 2 insiders
- Sold, last 12 months
- $2.18M 37 sales by 8 insiders
- Filings on record
- 566 since 2021-07-12, latest 2026-09-22 16:34
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Pale Fire Capital SICAV a.s. | 10% | $18.30M | — |
| Pale Fire Capital SE | 10% | $10.46M | — |
| Hoffman Allison C | GC, Sec | — | $537.1K |
| Indig Chaim | CEO, Dir | — | $421.0K |
| Linetsky David | Pres, Network Solutions | — | $347.2K |
| Gandhi Balaji | CFO | — | $291.8K |
| Roberts Evan | Pres, Provider Solutions | — | $281.9K |
| Hui Yvonne | Principal Accounting Off | — | $168.5K |
| VanDuyn Amy Beth | SVP, Human Resources | — | $105.8K |
| Egbuonu-Davis Lisa | Dir | — | $30.0K |
Transactions 672
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-01 | 2022-01-31 | PHR | Goldstein Lainie | Dir | A - Grant | $31.19 | +280 | 14.6K | +2% | +$8,733 | |
| 2022-02-01 | 2022-01-31 | PHR | CAHILL EDWARD L | Dir | A - Grant | $31.19 | +280 | 29.0K | +1.0% | +$8,733 | |
| D | 2022-01-24 | 2022-01-21 | PHR | Roberts Evan | COO | M - OptEx | $2.03 | +25.0K | 714.0K | +4% | +$50.7K |
| M | 2022-01-21 | 2022-01-19 | PHR | Rasmussen Randy | CFO | S - Sale | $32.66 | -2,228 | 128.9K | -2% | -$72.8K |
| 2022-01-19 | 2022-01-15 | PHR | Hoffman Allison C | GC, Sec | F - Tax | $35.55 | -879 | 116.2K | -0.8% | -$31.2K | |
| 2022-01-19 | 2022-01-14 | PHR | Hoffman Allison C | GC, Sec | A - Grant | $0.00 | +35.2K | 117.1K | +43% | $0 | |
| 2022-01-19 | 2022-01-14 | PHR | VanDuyn Amy Beth | SVP, Human Resources | A - Grant | $0.00 | +22.5K | 73.4K | +44% | $0 | |
| M | 2022-01-19 | 2022-01-15+ | PHR | VanDuyn Amy Beth | SVP, Human Resources | F - Tax | $35.55 | -2,865 | 71.0K | -4% | -$101.9K |
| 2022-01-19 | 2022-01-15 | PHR | Rasmussen Randy | CFO | F - Tax | $35.55 | -849 | 129.9K | -0.6% | -$30.2K | |
| 2022-01-19 | 2022-01-14 | PHR | Rasmussen Randy | CFO | A - Grant | $0.00 | +53.4K | 130.8K | +69% | $0 | |
| 2022-01-19 | 2022-01-14 | PHR | Indig Chaim | CEO, Dir | A - Grant | $0.00 | +91.4K | 1.22M | +8% | $0 | |
| M | 2022-01-19 | 2022-01-15+ | PHR | Indig Chaim | CEO, Dir | F - Tax | $35.55 | -57.6K | 1.20M | -5% | -$2.05M |
| 2022-01-19 | 2022-01-14 | PHR | Linetsky David | SVP, Life Sciences | A - Grant | $0.00 | +53.4K | 224.8K | +31% | $0 | |
| M | 2022-01-19 | 2022-01-15+ | PHR | Linetsky David | SVP, Life Sciences | F - Tax | $35.55 | -4,667 | 220.5K | -2% | -$165.9K |
| 2022-01-19 | 2022-01-14 | PHR | Davidoff Michael J. | See remarks | A - Grant | $0.00 | +35.2K | 118.1K | +42% | $0 | |
| M | 2022-01-19 | 2022-01-15+ | PHR | Davidoff Michael J. | See remarks | F - Tax | $35.55 | -5,442 | 113.9K | -5% | -$193.5K |
| M | 2022-01-19 | 2022-01-15+ | PHR | Roberts Evan | COO | F - Tax | $35.55 | -11.3K | 690.8K | -2% | -$401.2K |
| 2022-01-19 | 2022-01-14 | PHR | Roberts Evan | COO | A - Grant | $0.00 | +53.4K | 700.3K | +8% | $0 | |
| D | 2022-01-12 | 2022-01-11 | PHR | Roberts Evan | COO | M - OptEx | $0.84 | +43.8K | 646.9K | +7% | +$36.8K |
| D | 2022-01-11 | 2022-01-07 | PHR | Indig Chaim | CEO, Dir | M - OptEx | $2.03 | +84.3K | 1.13M | +8% | +$171.1K |
| DM | 2022-01-07 | 2022-01-06 | PHR | Linetsky David | SVP, Life Sciences | M - OptEx | $5.32 | +30.9K | 164.7K | +23% | +$164.7K |
| 2022-01-05 | 2021-12-31 | PHR | Rasmussen Randy | CFO | A - Grant | $35.41 | +342 | 77.3K | +0.4% | +$12.1K | |
| 2022-01-05 | 2021-12-31 | PHR | Hoffman Allison C | GC, Sec | A - Grant | $35.41 | +137 | 81.9K | +0.2% | +$4,851 | |
| 2022-01-05 | 2021-12-31 | PHR | Indig Chaim | CEO, Dir | G - Gift | $0.00 | -255.0K | 1.04M | -20% | $0 | |
| D | 2022-01-04 | 2021-12-31 | PHR | Davidoff Michael J. | See remarks | M - OptEx | $4.71 | +6,399 | 83.0K | +8% | +$30.1K |
| D | 2021-12-10 | 2021-12-09 | PHR | Indig Chaim | CEO, Dir | M - OptEx | $2.03 | +50.0K | 1.30M | +4% | +$101.5K |
| D | 2021-12-10 | 2021-12-09 | PHR | Roberts Evan | COO | M - OptEx | $0.84 | +50.0K | 603.1K | +9% | +$42.0K |
| 2021-11-12 | 2021-11-09 | PHR | Rasmussen Randy | CFO | S - Sale | $73.98 | -7,185 | 77.0K | -9% | -$531.5K | |
| DM | 2021-11-09 | 2021-11-05+ | PHR | Linetsky David | SVP, Life Sciences | S - Sale+OE | $75.14 | -4,977 | 140.4K | -3% | -$374.0K |
| DM | 2021-11-09 | 2021-11-05+ | PHR | Linetsky David | SVP, Life Sciences | M - OptEx | $4.71 | +4,977 | 141.9K | +4% | +$23.4K |
| 2021-11-09 | 2021-11-06 | PHR | Rasmussen Randy | CFO | F - Tax | $73.81 | -2,862 | 84.2K | -3% | -$211.2K | |
| D | 2021-11-02 | 2020-10-21 | PHR | VanDuyn Amy Beth | SVP, Human Resources | M - OptEx | $2.03 | +9,281 | 61.7K | +18% | +$18.8K |
| D | 2021-11-02 | 2020-10-21 | PHR | VanDuyn Amy Beth | SVP, Human Resources | S - Sale+OE | $35.00 | -10.8K | 50.9K | -18% | -$379.2K |
| M | 2021-11-02 | 2021-07-30+ | PHR | CAHILL EDWARD L | Dir | A - Grant | $69.43 | +252 | 28.7K | +0.9% | +$17.5K |
| M | 2021-11-02 | 2021-07-30+ | PHR | Goldstein Lainie | Dir | A - Grant | $69.43 | +252 | 14.2K | +2% | +$17.5K |
| D | 2021-11-02 | 2021-11-01 | PHR | Linetsky David | SVP, Life Sciences | M - OptEx | $4.71 | +5,451 | 145.8K | +4% | +$25.7K |
| DM | 2021-11-02 | 2021-11-01 | PHR | Linetsky David | SVP, Life Sciences | S - Sale+OE | $70.88 | -5,451 | 140.4K | -4% | -$386.4K |
| D | 2021-10-15 | 2021-10-15 | PHR | Linetsky David | SVP, Life Sciences | M - OptEx | $4.71 | +5,452 | 145.8K | +4% | +$25.7K |
| D | 2021-10-15 | 2021-10-15 | PHR | Linetsky David | SVP, Life Sciences | S - Sale+OE | $65.36 | -5,452 | 140.4K | -4% | -$356.3K |
| M | 2021-10-04 | 2021-10-01 | PHR | Sayar Ramin | Dir | A - Grant | $0.00 | +4,797 | 2,808 | New | $0 |
| DM | 2021-09-02 | 2021-08-31+ | PHR | Linetsky David | SVP, Life Sciences | M - OptEx | $4.71 | +5,452 | 145.4K | +4% | +$25.7K |
| DM | 2021-09-02 | 2021-08-31+ | PHR | Linetsky David | SVP, Life Sciences | S - Sale+OE | $70.54 | -5,452 | 140.4K | -4% | -$384.6K |
| DM | 2021-08-31 | 2021-08-27+ | PHR | Indig Chaim | CEO, Dir | S - Sale+OE | $71.83 | -112.2K | 1.28M | -8% | -$8.06M |
| DM | 2021-08-31 | 2021-08-27+ | PHR | Indig Chaim | CEO, Dir | M - OptEx | $5.42 | +112.2K | 1.30M | +9% | +$608.4K |
| DM | 2021-08-31 | 2021-08-27 | PHR | Linetsky David | SVP, Life Sciences | S - Sale+OE | $71.85 | -21.5K | 140.4K | -13% | -$1.54M |
| D | 2021-08-31 | 2021-08-27 | PHR | Linetsky David | SVP, Life Sciences | M - OptEx | $2.55 | +21.5K | 161.8K | +15% | +$54.7K |
| DM | 2021-08-27 | 2021-08-25+ | PHR | Linetsky David | SVP, Life Sciences | S - Sale+OE | $70.06 | -1,300 | 140.4K | -0.9% | -$91.1K |
| DM | 2021-08-27 | 2021-08-25+ | PHR | Linetsky David | SVP, Life Sciences | M - OptEx | $2.55 | +1,300 | 141.2K | +0.9% | +$3,315 |
| DM | 2021-08-27 | 2021-08-25+ | PHR | Indig Chaim | CEO, Dir | M - OptEx | $4.71 | +1,400 | 1.25M | +0.1% | +$6,594 |
| DM | 2021-08-27 | 2021-08-25+ | PHR | Indig Chaim | CEO, Dir | S - Sale+OE | $70.04 | -1,400 | 1.25M | -0.1% | -$98.1K |
| 2021-08-26 | 2021-08-25 | PHR | Hoffman Allison C | GC, Sec | S - Sale | $69.05 | -2,082 | 81.8K | -2% | -$143.8K | |
| 2021-08-26 | 2021-08-24 | PHR | Hoffman Allison C | GC, Sec | F - Tax | $69.54 | -2,577 | 83.9K | -3% | -$179.2K | |
| M | 2021-08-09 | 2021-08-05 | PHR | VanDuyn Amy Beth | SVP, Human Resources | S - Sale | $69.58 | -5,273 | 55.8K | -9% | -$366.9K |
| D | 2021-08-09 | 2021-08-05 | PHR | Weintraub Michael | Dir | S - Sale+OE | $70.13 | -8,236 | 167.1K | -5% | -$577.6K |
| D | 2021-08-09 | 2021-08-05 | PHR | Weintraub Michael | Dir | M - OptEx | $2.03 | +8,236 | 175.3K | +5% | +$16.7K |
| DM | 2021-08-09 | 2021-08-05+ | PHR | Indig Chaim | CEO, Dir | S - Sale+OE | $70.28 | -29.8K | 1.25M | -2% | -$2.09M |
| DM | 2021-08-09 | 2021-08-05+ | PHR | Indig Chaim | CEO, Dir | M - OptEx | $4.71 | +29.8K | 1.28M | +2% | +$140.3K |
| DM | 2021-08-02 | 2021-07-29+ | PHR | Weintraub Michael | Dir | S - Sale+OE | $70.02 | -1,764 | 167.1K | -1% | -$123.5K |
| DM | 2021-08-02 | 2021-07-29+ | PHR | Weintraub Michael | Dir | M - OptEx | $2.03 | +1,764 | 168.8K | +1% | +$3,581 |
| DM | 2021-08-02 | 2021-07-29+ | PHR | Indig Chaim | CEO, Dir | M - OptEx | $2.48 | +6,881 | 1.25M | +0.6% | +$17.1K |
| DM | 2021-08-02 | 2021-07-29+ | PHR | Indig Chaim | CEO, Dir | S - Sale+OE | $70.03 | -6,881 | 1.25M | -0.5% | -$481.9K |
| DM | 2021-07-22 | 2021-07-20+ | PHR | Weintraub Michael | Dir | M - OptEx | $2.03 | +10.0K | 169.6K | +6% | +$20.3K |
| DM | 2021-07-22 | 2021-07-20+ | PHR | Weintraub Michael | Dir | S - Sale+OE | $65.10 | -10.0K | 167.1K | -6% | -$651.0K |
| D | 2021-07-20 | 2021-07-16 | PHR | Weintraub Michael | Dir | M - OptEx | $2.03 | +20.0K | 187.1K | +12% | +$40.6K |
| DM | 2021-07-20 | 2021-07-16 | PHR | Weintraub Michael | Dir | S - Sale+OE | $63.76 | -20.0K | 173.8K | -10% | -$1.28M |
| 2021-07-12 | 2021-07-08 | PHR | CAHILL EDWARD L | Dir | A - Grant | $0.00 | +2,605 | 28.5K | +10% | $0 | |
| 2021-07-12 | 2021-07-08 | PHR | Goldstein Lainie | Dir | A - Grant | $0.00 | +2,605 | 14.1K | +23% | $0 | |
| M | 2021-07-12 | 2021-07-08 | PHR | Munson Gillian | Dir | S - Sale | $63.19 | -3,055 | 20.7K | -13% | -$193.0K |
| 2021-07-12 | 2021-07-08 | PHR | Munson Gillian | Dir | A - Grant | $0.00 | +2,605 | 23.0K | +13% | $0 | |
| 2021-07-12 | 2021-07-08 | PHR | Pegus Cheryl | Dir | A - Grant | $0.00 | +2,605 | 15.8K | +20% | $0 | |
| 2021-07-12 | 2021-07-08 | PHR | Weintraub Michael | Dir | A - Grant | $0.00 | +2,605 | 167.1K | +2% | $0 | |
| 2021-07-12 | 2021-07-08 | PHR | Smith Mark Douglas | Dir | A - Grant | $0.00 | +2,605 | 8,715 | +43% | $0 |
Purchase Sale Sale after option exercise All abbreviations